ArticleMolecular neurobiology2025
Photobiomodulation Reduces Fibrous Scar Formation After Spinal Cord Injury by Downregulating CXCL3 Expression in Macrophages.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Although the inhibitory role of photobiomodulation (PBM) in glial scar formation after spinal cord injury (SCI) has been identified, its effects on fibrous scar formation and the underlying mechanisms remain unexplored. To assess fibrous scar deposition, Sirius Red, Masson's trichrome, and immunostaining of extracellular matrix molecules after SCI were performed. Fibroblast viability was evaluated using the CCK-8 assay, whereas migration capacity was measured using Transwell and scratch assays. RNA sequencing was performed on macrophages subjected to inflammation with and without PBM intervention. To validate the mechanism in vivo, CXCL3 and a CXCR2 inhibitor were administered to mice intraperitoneally. Findings demonstrated that PBM treatment suppressed fibrous scar formation post-SCI. Temporal profiling revealed distinct patterns of macrophage and fibroblast infiltration after injury, with fibroblast migration influenced by the macrophage-conditioned medium. RNA sequencing analysis identified CXCL3 as a key mediator of macrophage-fibroblast crosstalk under PBM modulation. More specifically, PBM downregulated CXCL3 expression in macrophages, thereby attenuating fibrous scar progression.
Indexed as
Identifiers
41407981What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.